Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure

Sara C. Johnston(United States Army Medical Research Institute of Infectious Diseases), Keersten M. Ricks(United States Army Medical Research Institute of Infectious Diseases), Alexandra Jay(United States Army Medical Research Institute of Infectious Diseases), Jo Lynne Raymond(United States Army Medical Research Institute of Infectious Diseases), Franco Rossi(United States Army Medical Research Institute of Infectious Diseases), Xiankun Zeng(United States Army Medical Research Institute of Infectious Diseases), Jennifer L. Scruggs(United States Army Medical Research Institute of Infectious Diseases), David Dyer(United States Army Medical Research Institute of Infectious Diseases), Ondraya Frick(United States Army Medical Research Institute of Infectious Diseases), Jeffrey W. Koehler(United States Army Medical Research Institute of Infectious Diseases), Paul A. Kuehnert(United States Army Medical Research Institute of Infectious Diseases), Tamara L. Clements(United States Army Medical Research Institute of Infectious Diseases), Charles J. Shoemaker(United States Army Medical Research Institute of Infectious Diseases), S. R. Coyne(United States Army Medical Research Institute of Infectious Diseases), Korey L. Delp(United States Army Medical Research Institute of Infectious Diseases), Joshua L. Moore(United States Army Medical Research Institute of Infectious Diseases), Kerry Berrier(United States Army Medical Research Institute of Infectious Diseases), Heather L. Esham(United States Army Medical Research Institute of Infectious Diseases), Joshua D. Shamblin(United States Army Medical Research Institute of Infectious Diseases), Willie Sifford(United States Army Medical Research Institute of Infectious Diseases), Jimmy Fiallos(United States Army Medical Research Institute of Infectious Diseases), Leslie Klosterman(United States Army Medical Research Institute of Infectious Diseases), Stephen Stevens(United States Army Medical Research Institute of Infectious Diseases), Lauren E. White(United States Army Medical Research Institute of Infectious Diseases), Philip A Bowling(United States Army Medical Research Institute of Infectious Diseases), Terrence Garcia(United States Army Medical Research Institute of Infectious Diseases), Christopher E. Jensen(United States Army Medical Research Institute of Infectious Diseases), Jeanean M Ghering(United States Army Medical Research Institute of Infectious Diseases), David Nyakiti(United States Army Medical Research Institute of Infectious Diseases), Stephanie A. Bellanca(United States Army Medical Research Institute of Infectious Diseases), Brian Kearney(United States Army Medical Research Institute of Infectious Diseases), Wendy Giles(United States Army Medical Research Institute of Infectious Diseases), Nazira A. Alli(United States Army Medical Research Institute of Infectious Diseases), Fabián Méndez(United States Army Medical Research Institute of Infectious Diseases), Kristen Akers(United States Army Medical Research Institute of Infectious Diseases), Denise K. Danner(United States Army Medical Research Institute of Infectious Diseases), James F. Barth(United States Army Medical Research Institute of Infectious Diseases), Joshua A. Johnson(United States Army Medical Research Institute of Infectious Diseases), Matthew Durant(United States Army Medical Research Institute of Infectious Diseases), Ruth Kim(United States Army Medical Research Institute of Infectious Diseases), Jay W. Hooper(United States Army Medical Research Institute of Infectious Diseases), Jeffrey M. Smith(United States Army Medical Research Institute of Infectious Diseases), Jeffrey R. Kugelman(United States Army Medical Research Institute of Infectious Diseases), Brett Beitzel(United States Army Medical Research Institute of Infectious Diseases), Kathleen Gibson(United States Army Medical Research Institute of Infectious Diseases), M. Louise M. Pitt(United States Army Medical Research Institute of Infectious Diseases), Timothy D. Minogue(United States Army Medical Research Institute of Infectious Diseases), Ayşegül Nalça(United States Army Medical Research Institute of Infectious Diseases)
PLoS ONE
February 2, 2021
Cited by 75Open Access
Full Text

Abstract

Airborne transmission is predicted to be a prevalent route of human exposure with SARS-CoV-2. Aside from African green monkeys, nonhuman primate models that replicate airborne transmission of SARS-CoV-2 have not been investigated. A comparative evaluation of COVID-19 in African green monkeys, rhesus macaques, and cynomolgus macaques following airborne exposure to SARS-CoV-2 was performed to determine critical disease parameters associated with disease progression, and establish correlations between primate and human COVID-19. Respiratory abnormalities and viral shedding were noted for all animals, indicating successful infection. Cynomolgus macaques developed fever, and thrombocytopenia was measured for African green monkeys and rhesus macaques. Type II pneumocyte hyperplasia and alveolar fibrosis were more frequently observed in lung tissue from cynomolgus macaques and African green monkeys. The data indicate that, in addition to African green monkeys, macaques can be successfully infected by airborne SARS-CoV-2, providing viable macaque natural transmission models for medical countermeasure evaluation.


Related Papers

No related papers found

Powered by citation graph analysis